Bicycle Therapeutics
BCYC | NASDAQ
$3.73
+$0.10 (+2.75%)
Sep 22, 2026, 1:47 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.24 | -4.81 | -3.56 | -7.79 | -22.80 | -6.75 |
PEG Ratio | -0.26 | 0.11 | -0.11 | -0.18 | -60.64 | 1.70 |
PS Ratio | 6.76 | 23.10 | 23.85 | 60.70 | 130.42 | 33.08 |
PB Ratio | 0.80 | 1.03 | 1.73 | 3.24 | 4.41 | 3.60 |
P/FCF Ratio | -1.94 | -4.91 | -10.12 | -8.35 | -90.67 | -18.10 |
P/OCF Ratio | -1.96 | -4.95 | -10.61 | -10.20 | -103.12 | -19.32 |
OCF/S Ratio | -343.97 | -466.97 | -224.75 | -595.39 | -126.48 | -171.21 |
Debt / Equity Ratio | 0.03 | 0.01 | 0.12 | 0.16 | 0.13 | 0.17 |
Quick Ratio | 11.98 | 13.81 | 8.08 | 6.92 | 12.65 | 6.73 |
Current Ratio | 11.98 | 13.81 | 8.08 | 6.92 | 12.65 | 6.73 |
Asset Turnover | 0.10 | 0.04 | 0.05 | 0.04 | 0.02 | 0.06 |
Interest Coverage | -1.2K | -121.31 | -58.21 | -34.88 | -21.99 | -113.70 |
Return on Equity | -35.90% | -21.31% | -48.71% | -41.63% | -19.30% | -53.44% |
Return on Assets | -30.51% | -17.66% | -30.35% | -27.45% | -13.93% | -31.65% |
Return on Invested Capital | -37.34% | -22.80% | -35.79% | -31.94% | -14.36% | -36.89% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | -390.34% | -480.13% | 100% | 100% | -219.05% |
Net Profit Margin | -301.66% | -479.18% | -669.72% | -779.35% | -571.25% | -490.95% |
Pretax Profit Margin | -301.45% | -492.69% | -664.32% | -789.88% | -585.47% | -497.92% |
Operating Profit Margin | -341.28% | -594.96% | -704.13% | -806.56% | -560.98% | -500.10% |
FCF Margin | -348.02% | -470.47% | -235.61% | -726.67% | -143.83% | -182.76% |
EBITDA Margin | -292.32% | -467.45% | -627.96% | -741.26% | -547.91% | -487.81% |
Add to Watchlist
Select watchlists to add or remove BCYC